Randomized Placebo-Controlled Trial of Anacetrapib

 

This interview with Christopher P. Cannon from Brigham and Women's Hospital, Boston, US discusses Randomized Placebo-Controlled Trial of Anacetrapib in 30,449 Patients with Atherosclerotic Vascular Disease at ESC 2017.